Urinary Activities of Proximal Tubule Enzymes in Neonates Treated with Gentamicin

Open access

Urinary Activities of Proximal Tubule Enzymes in Neonates Treated with Gentamicin

In order to determine the nephrotoxicity of gentamicin, an aminoglycoside antibiotic, activity of the enzymes dominantly localized in proximal tubules, i.e. alanine aminopeptidase (AAP), γ-glutamyl transferase (GGT) and N-acetylβ-D-glucosaminidase (NAG) was examined. Determinations were performed in 12-h urine samples of 30 neonates i.v. receiving gentamicin against Gram negative infections in daily doses of 5.0 mg/kg body mass for 10 consecutive days. The activities of the same enzymes were measured in 12-h urine samples of 30 examinées of the control group. The groups consisted of neonates of both sexes. The pretreatment period lasted for 5 days. On day 8 of gentamicin application, statistically significant differences in the activity of AAP and GGT expressed in U/mmol creatinine between the gentamicin-receiving and control group (p<0.01) were found. No significant differences in NAG activity of the gentamicin-treated group in comparison with the control were recorded during the 10-day gentamicin therapy. It can be concluded that 10-day treatment of neonates with usually prescribed gentamicin doses results in mild nephrotoxic changes close to the end of the therapy accompanied by increased activity of both urinary AAP and GGT, known as very sensitive indicators of nephrotoxicity. During the same treatment period no changes in NAG activity were observed, meaning that the antibiotic causes no severe injuries to proximal tubule cells at the level of cellular organelles.

Musso CG. Aminoglycosides and nephropathy. Electron J Biomed 2004; 2: 2-4.

Cuzzocrea S, Mazzon E, Dugo L Serraino I, Di Paola R, Britti D, et al. A role for superoxide in gentamicin-mediated nephropathy in rats. Eur J Pharmacol 2002; 450: 76-9.

Trajtnar F. Urinary enzymes as indicators of aminoglycoside nephrotoxicity. Folia Pharm Univ Carol 1995; 19: 91-9.

Van der Harst MR, Bull S, Laffont CM, Klein WR. Gentamicin nephrotoxicity - a comparison of in vitro findings with in vivo experiments in equines. Vet Res Commun 2005; 29: 247-61.

Lenz FM, Bright J, Knight R, Westwood FR, Davies D, Major H, et al. Metabonomics with 1H-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat. Biomarkers 2005; 10: 173-87.

Rossier Y, Divers TJ, Sweeney RW. Variations in urinary gamma-glutamyltransferase/urinary creatinine ratio in horses with or without pleuropneumonia treated with gentamicin. Equine Vet J 1995; 27: 217-20.

Derakhshanfar A, Bidadkosh A, Yazdi A. Dopamine protects gentamicin early induced nephrotoxicity in Sprague-Dawely rats. Comp Clin Pathol 2008; 17: 99-104.

Kavukcu S, Soylu A, Turkmen M. The clinical value of urinary N-acetyl-beta-D-glucosaminidase levels in childhood age group. Acta Med Okayama 2002; 56: 7-11.

Wiland P, Szechcinski J. Proximal tubule damage in patients treated with gentamicin or amikacin. Pol J Pharmacol 2003; 55: 631-7.

Kos M, Jazwinska-Taranawska E, Hurkacz M, Orzechowska-Juzwenko K, Pilecki W, Klempons J. The influence of locally implanted high doses of gentamicin on hearing and renal function of newborns treated for acute hematogenous osteomyelitis. Int J Clin Pharmacol Ther 2003; 41: 281-6.

Davidović B, Predojević-Samardžić J, Uletilović S, Malčić D, Saničanin Ž. Activities of proximal tubule enzymes in urine of patients treated with gentamicin. J Med Biochem 2007; 26: 46-50.

Mohammadi-Karakani A, Asgharzadeh-Haghighi S, Ghazi-Khansari M, Seyed-Ebrahimi A, Ghasemi A, Jaberi E. Enzymuria determination in children with aminoglycoside drugs. Hum Exp Toxicol 2008; 12: 879-82.

Cosgrove SE, Vigliani GA, Fowler VG, Abrutyn E, Corey GR, Levine DP, et al. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis 2009; 48: 713-21.

Werner M, Maruhn D, Atoba M. Use of gel filtration in the assay of urinary enzymes. J Chromatog 1969; 40: 254-63.

Jung K, Scholz D. An optimized assay of alanine aminopeptidase activity in urine. Clin Chem 1980; 26: 1251-4.

Persijn JP, Van der Slik W. A new method for the determination of gamma-glutamyltransferase in serum. J Clin Chem Clin Biochem 1976; 14: 421-7.

Szasz G. A kinetic colorimetric method for determination of gamma-glutamyltranspeptidase in serum. Z Klin Chem Klin Biochem 1974; 12: 228-32.

Maksime J, Saito E, Obuchi M, Kanayama M, Harakawa K, Yosida U. Improved kinetic rate assay of urinary N-acetyl-beta-D-glucosaminidase with 2-chloro-4-nitrophenyl-N-acetyl-beta-D-glucosaminidase as substrate. Clin Chem 1990; 36: 319-22.

Bartels H, Böhmer M. Eine Mikromethode zur Kreatininbestimmung. Clin Chim Acta 1971; 32: 81-5.

Heimann G. Renal toxicity of aminoglycosides in the neonatal period. Pediatr Pharmacol 1983; 3: 254-7.

Vezmar S, Bode U, Jaehde U. Methotrexate-associated biochemical alterations in a patient with chronic neurotoxicity. Journal of Medical Biochemistry 2009; 28: 11-15.

Alijado FJ, Garcia S. Insuficiencia renal aguda por nefrotoxicos. In Liano F, Pascual J (eds). Insuficiencia renal aguda. Barcelona, Masson 2000: 143-6.

Simeoni U, Schnitzler B, Massfelder T, Hirt C, Koehl C, Hamel G, et al. Specific development of lysosomal and brush border enzymuria in the human. Biol Neonate 1994; 65: 1-6.

Journal of Medical Biochemistry

The Journal of Society of Medical Biochemists of Serbia

Journal Information

IMPACT FACTOR 2018: 2,000
5-year IMPACT FACTOR: 1,075

CiteScore 2018: 1.47

SCImago Journal Rank (SJR) 2018: 0.523
Source Normalized Impact per Paper (SNIP) 2018: 0.581


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 145 97 30
PDF Downloads 79 67 8